financetom
Business
financetom
/
Business
/
MarketAxess Average Daily Volume Rises in November vs Year Ago
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MarketAxess Average Daily Volume Rises in November vs Year Ago
Dec 4, 2024 6:12 AM

08:37 AM EST, 12/04/2024 (MT Newswires) -- MarketAxess Holdings ( MKTX ) said Wednesday its total average daily volume came in at $44.95 billion in November, up 56% from a year earlier but down 3% compared to October.

Total rates ADV was $30.7 billion in November, up 112% from a year ago, but down 2% compared to October, the company said.

High-grade credit ADV was $6.53 billion in November, compared with $6.52 billion a year earlier, while high-yield credit ADV was $1.31 billion last month, compared to $1.91 billion a year ago, the company said.

MarketAxess ( MKTX ) shares fell more than 3% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fairfax Asia Chairman/CEO Athappan Passes Away
Fairfax Asia Chairman/CEO Athappan Passes Away
May 24, 2024
06:31 AM EDT, 05/24/2024 (MT Newswires) -- Fairfax Financial ( FRFHF ) overnight Thursday said Fairfax Asia Chairman and CEO Ramaswamy Athappan has passed away. The company didn't mention the cause of death or Athappan's age. He played a major role in developing Fairfax's insurance operations in Southeast Asia, the company said. Mr. Athappan was an exceptional leader with an...
Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
May 24, 2024
May 24 (Reuters) - Novo Nordisk's Ozempic slowed the worsening of kidney dysfunction in patients with type 2 diabetes and lowered the risk of kidney failure, heart problems, stroke and death, according to detailed results from a late-stage trial presented on Friday. The company in March reported that the diabetes drug known chemically as semaglutide cut the combined risk of...
Workday Cuts Fiscal 2025 Subscription Revenue Guidance Despite First-Quarter Beat
Workday Cuts Fiscal 2025 Subscription Revenue Guidance Despite First-Quarter Beat
May 24, 2024
06:30 AM EDT, 05/24/2024 (MT Newswires) -- Workday (WDAY) shares tanked early Friday as the cloud human resources company lowered its full-year subscription sales outlook amid slowing headcount growth, despite recording better-than-expected fiscal first-quarter results. Subscription revenue is now set to come in between $7.7 billion and $7.73 billion for fiscal 2025, representing annual gains of about 17%, the company...
Update: Workday Fiscal Q1 Earnings, Revenue Rise; FY 2025 Subscription-Revenue Guidance Cut; Shares Sink Premarket
Update: Workday Fiscal Q1 Earnings, Revenue Rise; FY 2025 Subscription-Revenue Guidance Cut; Shares Sink Premarket
May 24, 2024
06:20 AM EDT, 05/24/2024 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Workday (WDAY) shares were down 12% in premarket activity on Friday after the company cut its fiscal 2025 subscription-revenue guidance, taking the shine out of its Q1 earnings and revenue beat. The company reported fiscal Q1 non-GAAP net income late Thursday...
Copyright 2023-2026 - www.financetom.com All Rights Reserved